This page lists the SEC filings reported by Roth Michael Anthony.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | Hicks Acquisition CO I Inc. | 9 | 11.0% | EDGAR |
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | Fibrocell Science, Inc. | 9 | 11.0% | EDGAR |
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | LIME ENERGY CO. | 9 | 11.0% | EDGAR |
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | LOJACK CORP | 9 | 11.0% | EDGAR |
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | Opexa Therapeutics, Inc. | 9 | 11.0% | EDGAR |
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | PLANETOUT INC | 9 | 11.0% | EDGAR |
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | TRANSGENOMIC INC | 9 | 11.0% | EDGAR |
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | TRANSGENOMIC INC | 9 | 11.0% | EDGAR |
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | CALYPTE BIOMEDICAL CORP | 9 | 11.0% | EDGAR |
| SC 13G/A | 2010-02-16 | Roth Michael Anthony | UROPLASTY INC | 9 | 11.0% | EDGAR |
| SC 13G | 2009-10-30 | Roth Michael Anthony | HeartWare International, Inc. | 9 | 11.0% | EDGAR |
| SC 13G | 2009-07-30 | Roth Michael Anthony | PRIMUS TELECOMMUNICATIONS GROUP INC | 9 | 11.0% | EDGAR |
| SC 13G | 2009-07-23 | Roth Michael Anthony | CLEVELAND BIOLABS INC | 9 | 11.0% | EDGAR |
| SC 13G/A | 2009-07-17 | Roth Michael Anthony | ISOLAGEN INC | 9 | 11.0% | EDGAR |
| SC 13G/A | 2009-07-09 | Roth Michael Anthony | ISOLAGEN INC | 9 | 11.0% | EDGAR |
| SC 13G | 2009-07-09 | Roth Michael Anthony | GUIDED THERAPEUTICS INC | 9 | 11.0% | EDGAR |
| SC 13G/A | 2009-06-02 | Roth Michael Anthony | NORTH AMERICAN SCIENTIFIC INC | - | - | EDGAR |
| SC 13G/A | 2009-02-18 | ROTH MICHAEL | CALYPTE BIOMEDICAL CORP | 27,454,567 | 5.9% | EDGAR |
| SC 13G/A | 2009-02-17 | ROTH MICHAEL | Alternative Asset Management Acquisition Corp. | - | - | EDGAR |
| SC 13G/A | 2009-02-17 | ROTH MICHAEL | AMERICAN LAND LEASE INC | - | - | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.